Geode Capital Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,292
| Closed | -$66.3K | – | 4813 |
|
|
2023
Q3 | $66.3K | Buy |
22,292
+2,493
| +13% | +$5.81K | ﹤0.01% | 4352 |
|
|
2023
Q2 | $48.1K | Hold |
19,799
| – | – | ﹤0.01% | 4512 |
|
|
2023
Q1 | $33.7K | Sell |
19,799
-94
| -0.5% | -$213 | ﹤0.01% | 4606 |
|
|
2022
Q4 | $34K | Buy |
19,893
+4,151
| +26% | +$10.1K | ﹤0.01% | 4691 |
|
|
2022
Q3 | $94K | Buy |
15,742
+10,955
| +229% | +$91.9K | ﹤0.01% | 4601 |
|
|
2022
Q2 | $75K | Buy |
4,787
+673
| +16% | +$9.81K | ﹤0.01% | 4679 |
|
|
2022
Q1 | $79K | Sell |
4,114
-5
| -0.1% | -$83 | ﹤0.01% | 4718 |
|
|
2021
Q4 | $78K | Hold |
4,119
| – | – | ﹤0.01% | 4787 |
|
|
2021
Q3 | $187K | Buy |
4,119
+842
| +26% | +$41.3K | ﹤0.01% | 4479 |
|
|
2021
Q2 | $199K | Buy |
3,277
+2,696
| +464% | +$189K | ﹤0.01% | 4345 |
|
|
2021
Q1 | $58K | Buy |
+581
| New | +$50K | ﹤0.01% | 4390 |
|
|
2020
Q2 | – | Sell |
-45
| Closed | -$8K | – | 4145 |
|
|
2020
Q1 | $8K | Hold |
45
| – | – | ﹤0.01% | 4093 |
|
|
2019
Q4 | $11K | Hold |
45
| – | – | ﹤0.01% | 4186 |
|
|
2019
Q3 | $8K | Hold |
45
| – | – | ﹤0.01% | 4182 |
|
|
2019
Q2 | $16K | Hold |
45
| – | – | ﹤0.01% | 4171 |
|
|
2019
Q1 | $59K | Hold |
45
| – | – | ﹤0.01% | 3990 |
|
|
2018
Q4 | $72K | Hold |
45
| – | – | ﹤0.01% | 3922 |
|
|
2018
Q3 | $127K | Hold |
45
| – | – | ﹤0.01% | 3881 |
|
|
2018
Q2 | $148K | Hold |
45
| – | – | ﹤0.01% | 3790 |
|
|
2018
Q1 | $155K | Buy |
45
+23
| +105% | +$68.2K | ﹤0.01% | 3754 |
|
|
2017
Q4 | $35K | Hold |
22
| – | – | ﹤0.01% | 3961 |
|
|
2017
Q3 | $92K | Hold |
22
| – | – | ﹤0.01% | 3839 |
|
|
2017
Q2 | $155K | Buy |
22
+21
| +2,100% | +$183K | ﹤0.01% | 3756 |
|
|
2017
Q1 | $8K | Buy |
+1
| New | +$6.92K | ﹤0.01% | 4062 |
|
Geode Capital Management's TMBR Position: Q4 2023 in Review
Geode Capital Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 22,292 shares — an estimated $66.3K sold.
Geode Capital Management first reported a position in TMBR in Q1 2017 and held it in 24 quarters. The position peaked at $199K in Q2 2021. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.
- Geode Capital Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Geode Capital Management sold 22,292 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $66.3K.
- Geode Capital Management first reported a position in Timber Pharmaceuticals, Inc. in Q1 2017 and held it in 24 quarters.
- Geode Capital Management's Timber Pharmaceuticals, Inc. position peaked at $199K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.